Journal: Advanced Science
Article Title: GLS1‐Mediated Redundancy in Glutamate Accelerates Arterial Calcification via Activating NMDAR/Ca 2+ / β ‐Catenin Pathway
doi: 10.1002/advs.202414252
Figure Lengend Snippet: Glutamate aggravates osteogenic reprogramming of VSMCs by activating NMDAR. A) Detection of extracellular glutamate released into the supernatant of cultured VSMCs from control and Pi with or without GLS1 overexpression ( n = 3). B) Measurement of extracellular glutamate released into the supernatant of cultured VSMCs from Pi with overexpression of GLS1 in the absence or presence of DL‐TBOA (a glutamate transport inhibitor, 100 µ m ) for 7 days ( n = 5). C,D) After overexpression of GLS1, VSMCs were incubated with Pi, and then exposed to glutamate receptor inhibitors ( LY341495 : mGlu inhibitor, 10 µ m ; CNQX: AMPAR inhibitor, 10 m m ; MK801: NMDAR inhibitor, 10 µ m ), respectively. The osteogenic reprogramming of VSMCs was investigated using Alizarin Red staining ( n = 3) and Calcium quantitative analysis ( n = 3). Scale bar: 200 µm. E,F) In the presence of GLS1 overexpression, western analysis of RUNX2 was performed in VSMCs treated with Pi and 3 different glutamate receptor inhibitors ( n = 3). G,H) Dose‐response relationship for the effect of MK801 on VSMCs with overexpression of GLS1 and Pi treatment was determined by calcium content assay ( n = 3) and Alizarin Red staining ( n = 3). Scale bar: 200 µm. I,J) Western Blots analysis of VSMCs overexpressing GLS1 and treated with Pi, both in the absence and presence of MK801 ( n = 4). K) The expression of GluN1 protein levels from VSMCs in the indicated group was measured by western blot assay ( n = 5). L) Representative Von Kossa staining (upper) and immunohistochemical staining of GluN1 (lower) in arteries with or without calcification from patients ( n = 5). Scale bar: 100 µm. Data are represented as means ± SEM. One‐way ANOVA with Bonferroni's test was used in (A), (B), (D), and (J), or Dunnett's test was used in (F) and (G).
Article Snippet: Treatments were carried out simultaneously with Pi stimulation: BPTES (Selleck); CB‐839 (Selleck, 1 μ m ); MK801 (APExBIO, 10 μ m ); CNQX (APExBIO, 10 μ m ); LY341495 (APExBIO, 10 μ m ); SCH772984 (APExBIO, 10 μ m ); U0126‐EtOH (APExBIO, 10 μ m ); BAPTA‐AM (Selleck, 5 m m ); DL‐TBOA (MCE, 100 μ m ) was selected as the working concentration.
Techniques: Cell Culture, Control, Over Expression, Incubation, Staining, Western Blot, Expressing, Immunohistochemical staining